| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.0055 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.0042 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |